Source · Prevention of Future Deaths

Olivia Russell

Ref: 2023-0528 Date: 14 Dec 2023 Coroner: Victoria Davies Area: Cheshire Responses identified: 1 / 1 View PDF

GPs may not routinely discuss medication risks, such as relapse or initial worsening symptoms, contradicting NICE guidance, due to varied approaches and time limitations. A significant event meeting regarding the death was also delayed for over two years.

Date 14 Dec 2023
56-day deadline 8 Feb 2024 est.
Responses identified 1 of 1
Suicide (from 2015)

Coroner's concerns

AI summary
GPs may not routinely discuss medication risks, such as relapse or initial worsening symptoms, contradicting NICE guidance, due to varied approaches and time limitations. A significant event meeting regarding the death was also delayed for over two years.
View full coroner's concerns
During the inquest, evidence was heard from , one of your salaried GPs as to his interactions with Olivia, and based on the records, his colleagues’ interactions. There was no evidence within the notes that the risk of relapse if a medication is stopped was discussed in either November 2020 or August 2021, nor is there evidence that Olivia was told she may feel worse before she feels better. I did not find that this advice was not given, simply that I could not say either way. When asked, evidence was that you would discuss the risks when prescribing the drug, but was not entirely clear as to which risks he would discuss, and gave evidence that it is likely each GP has a different approach, bearing in mind the time limitations of the appointment. He could not say with confidence that every GP within the practice was discussing these key risks. A copy of the relevant NICE guidance was provided to me which states that these risks should be discussed with the patient, and I look specifically at sections 1.3.1 and 1.5.2 as a minimum. I am concerned that this guidance is not being followed as a matter of routine within the surgery and that this gives rise to a risk of future deaths. I am also concerned that a significant event meeting (acknowledging I may have the name of this review meeting incorrect) has not yet taken place, despite Olivia’s death being over 2 years ago. The evidence of was that this will take place after the inquest and I am concerned that, if this is the practice following all deaths, there is a risk that learning from deaths will be delayed or missed.

Responses

1 respondent
Stretton Branch Surgery Other
PDF
Action Planned

The practice will audit care plans every 6 months, request GP review earlier than 2 weeks if needed, refer to CRISIS team for deterioration, have the Clinical pharmacist assist with medication review and arrange a follow-up appointment for any patients that DNA. (AI summary)

View full response
Dear Ms Davies I write on behalf of the Stretton Medical Centre in response to your Regulation 28: report to prevent future deaths, dated 14 December 2023. We would like to thank you for bringing your concerns to the attention of the Practice and we wish to reassure you that the care and support of our patients is of the utmost importance to us. As a Practice, we were extremely saddened by Olivia’s death, and we wish to once again offer our sincere condolences to Olivia’s family. On 2 January 2024, the Practice conducted a clinical meeting / significant event meeting with our GP principal, , our salaried GP, , our regular Locum doctor, was unable to attend in person as she was working as locum doctor elsewhere at the time. We, as a practice, updated her on the discussion and the outcome. The purpose of the meeting was to discuss the outcome of the inquest and discuss the information and concerns detailed in the Regulation 28 report. We have considered the concerns and our response and action to each is below:
1. There was no Significant Event Meeting following Olivia’s death: The original information received from the hospital as notification of Death had limited information and detailed cause of death as cardiac arrest rather than apparent suicide. Therefore, at the time of Olivia’s death, a Significant Event Meeting was not carried out as the Practice awaited further information from the hospital report.

Stretton Medical Centre Stretton Branch Surgery 5 Hatton Lane Stretton 43-45 Dudlow Green Road Warrington Appleton WA4 4NE Warrington WA4 5EQ

A SEA was conducted on 2 January 2024. The Practice accepts that an SEA should have been performed sooner and prior to the inquest to ensure that learning from the death was identified as soon as possible and changes made to systems or practice where required. This was an oversight on our part, and the Practice would like to apologise for the delay. This learning is shared with all the clinicians in our practice and will be shared with clinicians in our primary care network for peer review. The Practice would like to reassure you that all patient deaths will be discussed at our monthly MDT meeting. We have revised our monthly Clinical Team Meeting template and every unexpected death will be discussed with a view to complete a Significant Event Analysis on them to share any learning. Where appropriate, the Significant Event Analysis of a death will be completed in a month, ready to discuss in the next monthly Clinical Team Meeting.
2. To ensure relevant information is shared with a patient when commencing an antidepressant, in accordance with relevant clinical guidelines. This includes a discussion about risks, in particular the risk of relapse when stopping a medication and the risk of increased self- harm ideation at the outset of treatment. As a result of the SEA on 2 January 2024, NICE Guidance (NG222 – Depression in adults: treatment and management) has been recirculated to all clinicians highlighting the need to appropriately discuss with patients any risks and in particular, the risk of relapse. Also, we shared a copy of the General Medical Council’s guidance on prescribing to doctors. We have implemented a system whereby whenever an antidepressant or an anti- anxiety medication is prescribed a note will be added to patient and pharmacist to confirm “please do not stop these medications without medical advice”. This note will show up on the medication box label. We have reminded all GPs that at the time of commencing an antidepressant, they should have a conversation with the patient mindful of the relevant clinical guidelines. The GP is then to book a follow up review with the patient. We have included this reminder in new starters and locum induction pack to ensure they act accordingly.

Stretton Medical Centre Stretton Branch Surgery 5 Hatton Lane Stretton 43-45 Dudlow Green Road Warrington Appleton WA4 4NE Warrington WA4 5EQ

To ensure risks are discussed with patients on anti-depressant medication, the Practice recognises that appointment times would need to be extended beyond the usual 10-minute slot. Hence patients booking to discuss a mental health concern will be given a 20-minute appointment. However, if a patient has not declared at the time of making the appointment that the appointment is to discuss a mental health concern, then the GP can send a message to reception to say that the consultation will take another 10 minutes and to keep any waiting patients informed of any delays. It is standard practice for our reception team to ask a patient the reason for their appointment at the time of booking an appointment to assist with planning the patient journey. There is no obligation on the patient to share information. While most patients declare their reasons for appointment some say it is “private” The Practice have agreed to book a review with the patient two weeks later where appropriate if medication has been commenced in relation to anxiety or depression symptoms. This should be then followed up with a medication review after 4 weeks where appropriate. Further appointments to be booked per advice from mental health practitioner, Talking Matters, counselling services or at patient request. The practice also has the option of signposting patients to the Practice Mental Health Nurses, to follow these patients up, to again sign post them to appropriate services like for CBT and counselling (to be another person who patient can speak to), to review their risk and get back to GP if they need any safeguarding put in place, to request GP to review them earlier than 2 weeks review as required, to refer them to CRISIS team if their mental health deteriorated in interim period. In addition, the Clinical pharmacist is available to assist with medication review to again discuss side effects of medications, to again discuss the importance of taking them regularly. The Clinical Pharmacist plays a vital role in prescribing weekly medications or even daily medications in patients who are at risk of taking an overdose. We have cascaded the outcomes of the Significant Event Analysis to all clinical members of our Practice team, which includes the reception and administration teams to ensure that they book the appropriate duration for each appointment and to reassure patients awaiting a consultation that they will be seen.

Stretton Medical Centre Stretton Branch Surgery 5 Hatton Lane Stretton 43-45 Dudlow Green Road Warrington Appleton WA4 4NE Warrington WA4 5EQ

We will arrange a follow-up appointment for any patients that DNA (did not attend) their appointment, with an ACCURX text message or a call when unable to send ACCURX text message. If the Practice can be of any further assistance to the Coroner, please let us know. Kind regards

Report sections

Investigation and inquest
On 23 September 2021 I commenced an investigation into the death of Olivia Amy RUSSELL aged 25. The investigation concluded at the end of the inquest on 6 December 2023. The conclusion of the inquest was one of suicide.
Circumstances of the death
Olivia Russell had a history of anxiety which was initial managed without medication. In October 2020 she contacted your surgery and discussed options to treat her anxiety as this had worsened. She initially decided against anti-depressants but subsequently had another appointment on 2 November where she opted for a 10mg dose of citalopram. Following a period of apparent stability, Olivia stopped taking her medication in or around June 2021 without consulting a GP, subsequently suffering a relapse and re-starting her medication in August 2021. Sadly, Olivia took her own life on 19 September 2021.

Similar PFD reports

Shared signals

Related inquiry recommendations

Similar themes

Report details

Reference
2023-0528
Date of report
14 December 2023
Coroner
Victoria Davies
Coroner area
Cheshire

Responses identified

Responses identified 1 of 1
All listed responses identified

Organisations named in PFD reports are normally expected to respond within 56 days. Deadline: 8 Feb 2024 (estimated).

Sent to

Stretton Medical Centre

Source links